Jack Huang - Atai Life President Director

ATAI
 Stock
  

USD 3.41  0.03  0.89%   

  President
Mr. Jack Huang is President, Director of the Company. Mr. Huang is a respected leader with over 20 years of involvement in the international education community. He most recently served as CEO of Lanxum Education, an online education and information security services provider in China, from 2015 to 2017. Prior to this, Mr. Huang worked at globally recognized education companies, including Chegg and Pearson. At Chegg, Mr. Huang oversaw Chegg China operation, and at Pearson, he served as the managing director of the Language Testing Division in Asia Pacific where he oversaw all language testing businesses in this region. Mr. Huang received an MBA from HEC Paris and an MSc from Edinburgh Napier University, graduating from both institutions with distinction
  President Since 2018      
49 89 2153 9035  https://www.atai.life
Huang also received a bachelor degree from Harbin Institute of Technology in China. He is a Fellow of the Chartered Institute of Marketing, the world leading marketing professionals body.

Atai Life Management Efficiency

Atai Life Sciences has return on total asset (ROA) of (37.52) % which means that it has lost $37.52 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (91.01) %, meaning that it created substantial loss on money invested by shareholders. Atai Life management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 725 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Atai Life Sciences has a current ratio of 15.47, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Atai Life until it has trouble settling it off, either with new capital or with free cash flow. So, Atai Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Atai Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Atai Life to invest in growth at high rates of return. When we think about Atai Life's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

PRESIDENT Since

Robert JohnsonCanadian Pacific Railway
2016
Jerome WallutAlstom Shs Prov
2015
Drew GlassmanCSX Corp
2015
Matthew BarkerCanadian National Railway
2016
John BrooksCanadian Pacific Railway
2019
Gregoire PouxGuillaumeAlstom Shs Prov
2011
Emmanuelle ChatelainAlstom Shs Prov
N/A
Kimberly MadiganCanadian National Railway
2018
Michael FosterCanadian National Railway
2018
JeanBaptiste EymeoudAlstom Shs Prov
2015
Takuhiro MorimotoWest Japan Railway
N/A
Tatsuo KijimaWest Japan Railway
2016
Tatsuya TanakaWest Japan Railway
N/A
Fumito OgataWest Japan Railway
2018
Lisa ManciniCSX Corp
N/A
Sean FinnCanadian National Railway
2017
Luc JobinCanadian National Railway
2016
Andrew GlassmanCSX Corp
2017
Yasuhiro AritaWest Japan Railway
N/A
Takaaki InoueWest Japan Railway
2013
Jeff LiepeltCanadian National Railway
2013
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. Atai Life Sciences (ATAI) is traded on NASDAQ Exchange in USA and employs 87 people.

Atai Life Sciences Leadership Team

Elected by the shareholders, the Atai Life's board of directors comprises two types of representatives: Atai Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atai Life. The board's role is to monitor Atai Life's management team and ensure that shareholders' interests are well served. Atai Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atai Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiaofeng Ma, Co-Founder, Chairman, CEO and Chairman of Nominations Committee
Yiu Tsui, Independent Director
Andrew Yan, Independent Director
ChengYaw Sun, CEO, Director
Jack Huang, President Director
Jun Zhang, President Director
Jianmin Ding, Sr. VP of Marketing and Bus. Devel.
Alex Tong, VP of Bus. Devel. and Investor Relations
Amy Tung, VP
Shuqiu Zhao, VP
Benson Tsang, Independent Consultant
Lin Wang, Co-Founder, Consultant and Director
Hope Ni, Independent Director

Atai Life Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Atai Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atai Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Pair Trading with Atai Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atai Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atai Life will appreciate offsetting losses from the drop in the long position's value.

Moving together with Atai Life

+0.72JPMJP Morgan Chase Earnings Call  Next WeekPairCorr
+0.68HPQHp Inc Fiscal Year End 22nd of November 2022 PairCorr
The ability to find closely correlated positions to Atai Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atai Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atai Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atai Life Sciences to buy it.
The correlation of Atai Life is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atai Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atai Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atai Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.